AMSTERDAM, the Netherlands — Nonselective beta-blocker therapy improves gastrointestinal permeability and decreases intestinal bacterial translocation in patients with cirrhosis and esophageal varices ...
Adding dapagliflozin (dapa) to the endothelin A receptor antagonist zibotentan (zibo) did not reduce hepatic venous pressure gradient (HVPG) or fluid retention in patients with compensated or ...